Eye Flu (Conjunctivitis) Market Growth Accelerated by Innovative Therapies

 


Frasier Syndrome is a rare genetic disorder characterized by gonadal dysgenesis in individuals with a 46,XY karyotype. Individuals with Frasier syndrome have ambiguous or female external genitalia and a small penis, undescended testes, or labia-like swelling instead of a scrotum. Frasier syndrome is caused due to mutations in the Wilms tumor 1(WT1) gene, which plays a critical role in the development of the gonads, kidneys, and other organs. Currently, no approved therapies exist for Frasier syndrome and treatment options are limited to supportive care and corrective surgery. However, the introduction of innovative gene and cell therapies hold promising potential to treat the underlying cause of Frasier syndrome.


The global Frasier Syndrome Market is estimated to be valued at US$ 141.2 Mn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The market growth is expected to be accelerated by innovative therapies. Several biotech companies are developing gene therapies targeting the WT1 gene to correct mutations causing Frasier syndrome. These therapies have shown promising preclinical efficacy and have potential to provide therapeutic effects for the lifetime of patients by a single intervention. Advancements in gene editing technologies like CRISPR are also facilitating development of curative therapies for Frasier syndrome. Successful clinical development and approval of these novel therapies will drive significant growth of the Frasier Syndrome Market during the forecast period.

Segment Analysis
The global Frasier Syndrome market is segmented by type into mild, moderate and severe. The severe segment accounts for the largest market share owing to large patient pool exhibiting severe symptoms of the syndrome. Patients with severe Frasier Syndrome often present nephrotic syndrome, renal dysfunction and cardiovascular complications at an early age making them highly dependent on long term management and care.

Key Takeaways
The global Frasier Syndrome market is expected to witness high growth during the forecast period of 2023 to 2030. The increasing awareness about the early diagnosis and management of the condition is expected to drive the demand.

Regional analysis: North America currently dominates the global Frasier Syndrome market and is expected to maintain its position over the forecast period. This can be attributed to the presence of major players and established healthcare infrastructure for efficient diagnosis and treatment in the region.

The key players operating in the Frasier Syndrome market are Pfizer Inc., AbbVie Inc. and Bayer AG. Pfizer offers nephrotic syndrome treatment options like ALKERA (digitecan) and AMILORIDE (Midamor). AbbVie's pharmaceutical portfolio includes medicines to treat protein in urine and control high blood pressure in patients suffering from Frasier Syndrome. Bayer provides selective aldosterone receptor antagonist drugs like SPIRONOLACTONE (Aldactone) which help control fluid retention and lower blood pressure in patients.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more